Intratendinous Genipin Injection in Horses With Tendon Injuries
Status:
Completed
Trial end date:
2023-01-04
Target enrollment:
Participant gender:
Summary
Our study is the first to use genipin, a naturally occurring collagen cross-linking agent, as
a therapeutic agent to treat superficial digital flexor tendon (SDFT) injuries in horses. The
promising approach of intratendinous genipin injection and tendon mechanical enhancement
could be a viable alternative to current therapies for SDFT injuries.